Physician Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
AstraZeneca
New data beta-blocker TOPROL-XL reported for pediatric hypertension treatment
June 15th, 2005
AstraZeneca announced new data for beta-blocker TOPROL-XL (metoprolol succinate) extended-release tablets in treating hypertension in pediatric patients. The data was presented at the 20th annual scientific meeting of the American Society of Hypertension (ASH) in San Francisco, California. This study adds to the established data on TOPROL-XL in the treatment of hypertension in adults. Hypertension affects one in three adults and approximately one in 100 children in the United States. "Hypertension in children is becoming increasingly common, in part related to the rise in childhood obesity. There is limited data on the treatment of pediatric...
Source: Physician Law Weekly (2005-06-15)
|
